Fu Y, Nawrocki E, Mikanatha N, Dudley E
Appl Environ Microbiol. 2024; 90(8):e0074924.
PMID: 39082811
PMC: 11337801.
DOI: 10.1128/aem.00749-24.
De Greve H, Fioravanti A
Front Immunol. 2024; 15:1334829.
PMID: 38827746
PMC: 11140111.
DOI: 10.3389/fimmu.2024.1334829.
Rim S, Vedoy O, Bronstad I, McCann A, Meyer K, Steinsland H
Med Microbiol Immunol. 2024; 213(1):2.
PMID: 38430452
PMC: 10908629.
DOI: 10.1007/s00430-024-00786-z.
Gore R, Mohsenipour M, Wood J, Balasuriya G, Hill-Yardin E, Franks A
Infect Immun. 2023; 91(11):e0009723.
PMID: 37830823
PMC: 10652967.
DOI: 10.1128/iai.00097-23.
Kuhlmann F, Grigura V, Vickers T, Prouty M, Iannotti L, Dulience S
Microorganisms. 2023; 11(9).
PMID: 37764065
PMC: 10536235.
DOI: 10.3390/microorganisms11092221.
The Promising Potential of Reverse Vaccinology-Based Next-Generation Vaccine Development over Conventional Vaccines against Antibiotic-Resistant Bacteria.
Khalid K, Poh C
Vaccines (Basel). 2023; 11(7).
PMID: 37515079
PMC: 10385262.
DOI: 10.3390/vaccines11071264.
A low-cost recombinant glycoconjugate vaccine confers immunogenicity and protection against enterotoxigenic infections in mice.
Williams A, Warfel K, Desai P, Li J, Lee J, Wong D
Front Mol Biosci. 2023; 10:1085887.
PMID: 36936989
PMC: 10018396.
DOI: 10.3389/fmolb.2023.1085887.
The role of bacterial vaccines in the fight against antimicrobial resistance: an analysis of the preclinical and clinical development pipeline.
Frost I, Sati H, Garcia-Vello P, Hasso-Agopsowicz M, Lienhardt C, Gigante V
Lancet Microbe. 2022; 4(2):e113-e125.
PMID: 36528040
PMC: 9892012.
DOI: 10.1016/S2666-5247(22)00303-2.
Comparative study of subcutaneous, intramuscular, and oral administration of bovine pathogenic bacterial ghost vaccine in mice.
Mu J, Lei L, Zheng Y, Li D, Li J, Fu Y
Front Immunol. 2022; 13:1008131.
PMID: 36451816
PMC: 9702981.
DOI: 10.3389/fimmu.2022.1008131.
Confronting challenges to enterotoxigenic vaccine development.
Fleckenstein J
Front Trop Dis. 2022; 2.
PMID: 35937717
PMC: 9355458.
DOI: 10.3389/fitd.2021.709907.
Controlled Human Infection Models To Accelerate Vaccine Development.
Choy R, Louis Bourgeois A, Ockenhouse C, Walker R, Sheets R, Flores J
Clin Microbiol Rev. 2022; 35(3):e0000821.
PMID: 35862754
PMC: 9491212.
DOI: 10.1128/cmr.00008-21.
Intramuscularly Administered Enterotoxigenic (ETEC) Vaccine Candidate MecVax Prevented H10407 Intestinal Colonization in an Adult Rabbit Colonization Model.
Upadhyay I, Lauder K, Li S, Ptacek G, Zhang W
Microbiol Spectr. 2022; 10(4):e0147322.
PMID: 35762781
PMC: 9431210.
DOI: 10.1128/spectrum.01473-22.
Enterotoxigenic : intestinal pathogenesis mechanisms and colonization resistance by gut microbiota.
Zhang Y, Tan P, Zhao Y, Ma X
Gut Microbes. 2022; 14(1):2055943.
PMID: 35358002
PMC: 8973357.
DOI: 10.1080/19490976.2022.2055943.
Protective efficacy of a novel multivalent vaccine in the prevention of diarrhea induced by enterotoxigenic in a murine model.
Zhao H, Xu Y, Li G, Liu X, Li X, Wang L
J Vet Sci. 2021; 23(1):e7.
PMID: 34841745
PMC: 8799940.
DOI: 10.4142/jvs.21068.
Genomic Epidemiology and Antimicrobial Susceptibility Profile of Enterotoxigenic From Outpatients With Diarrhea in Shenzhen, China, 2015-2020.
Yang C, Li Y, Zuo L, Jiang M, Zhang X, Xie L
Front Microbiol. 2021; 12:732068.
PMID: 34777281
PMC: 8581654.
DOI: 10.3389/fmicb.2021.732068.
Epidemiology and Characterization of Shiga Toxin-Producing Escherichia Coli of Hemolytic Uremic Syndrome in Argentina.
Torti J, Cuervo P, Nardello A, Pizarro M
Cureus. 2021; 13(8):e17213.
PMID: 34540440
PMC: 8443070.
DOI: 10.7759/cureus.17213.
Anti-CfaE nanobodies provide broad cross-protection against major pathogenic enterotoxigenic Escherichia coli strains, with implications for vaccine design.
Amcheslavsky A, Wallace A, Ejemel M, Li Q, McMahon C, Stoppato M
Sci Rep. 2021; 11(1):2751.
PMID: 33531570
PMC: 7854682.
DOI: 10.1038/s41598-021-81895-0.
A One Health Perspective for Defining and Deciphering Pathogenic Potential in Multiple Hosts.
Garcia A, Fox J
Comp Med. 2021; 71(1):3-45.
PMID: 33419487
PMC: 7898170.
DOI: 10.30802/AALAS-CM-20-000054.
Establishment and Validation of Pathogenic CS17 and CS19 Enterotoxigenic Escherichia coli Challenge Models in the New World Primate Aotus nancymaae.
Hall E, ODowd A, Rollenhagen J, Espinoza N, Nunez G, Savarino S
Infect Immun. 2020; 89(3).
PMID: 33288648
PMC: 8097270.
DOI: 10.1128/IAI.00479-20.
Chaperone-tip adhesin complex is vital for synergistic activation of CFA/I fimbriae biogenesis.
He L, Wang H, Liu Y, Kang M, Li T, Li C
PLoS Pathog. 2020; 16(10):e1008848.
PMID: 33007034
PMC: 7531860.
DOI: 10.1371/journal.ppat.1008848.